IMARC Group’s report titled “Helicobacter Pylori Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033”. The global helicobacter pylori diagnostics market size reached USD 585.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 918.8 Million by 2033, exhibiting a growth rate (CAGR) of 4.72% during 2025-2033.

Factors Affecting the Growth of the Helicobacter Pylori Diagnostics Industry:  

• Increasing Incidence of Gastric Disorders:

Helicobacter (H.) pylori infection is a leading cause of various gastric disorders, including gastritis, peptic ulcers, and gastric cancer. As the incidence of these disorders is rising, there is a greater need to accurately identify the underlying cause, which often involves testing for H. pylori infection. Moreover, early detection of H. pylori infection is crucial for effective management and prevention of complications, such as peptic ulcers and gastric cancer. As the incidence of gastric disorders is increasing, there is a greater emphasis on early diagnosis through H. pylori testing to initiate timely treatment and prevent disease progression.

• Technological Advancements:

Innovations in diagnostic technologies are leading to the development of tests with improved accuracy and sensitivity for detecting H. pylori infection. Newer methods, such as molecular diagnostic techniques like polymerase chain reaction (PCR) assays, offer higher sensitivity and specificity compared to traditional methods, leading to more reliable results and better patient outcomes. Furthermore, technological advancements are facilitating the development of non-invasive diagnostic tests for H. pylori, such as stool antigen tests and urea breath tests. These tests offer advantages over invasive procedures like endoscopy, including greater patient comfort, reduced risk of complications, and easier administration, thereby driving market adoption.

• Rising Healthcare Expenditure:

As healthcare expenditure is rising, individuals have greater access to healthcare services, including diagnostic testing for conditions like H. pylori infection. Increasing access to healthcare facilities and diagnostic services is leading to higher testing rates and greater demand for H. pylori diagnostics. In addition, higher healthcare expenditure often translates into investment in healthcare infrastructure, including the establishment of diagnostic laboratories and healthcare facilities equipped with advanced diagnostic technologies. This expansion of infrastructure enhances the availability and accessibility of H. pylori diagnostic tests.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/helicobacter-pylori-diagnostics-market/requestsample

Leading Companies Operating in the Global Helicobacter Pylori Diagnostics Industry:

• Abbott Laboratories
• Avanos Medical, Inc.
• Biohit Oyj
• Bio-Rad Laboratories, Inc.
• Cardinal Health Inc.
• CerTest Biotec S.L.
• Coris BioConcept (Avacta Group)
• CTK Biotech Inc. (SSI Diagnostica A/S Group)
• Epitope Diagnostics, Inc.
• Gulf Coast Scientific Inc.
• Meridian Bioscience, Inc. (SD Biosensor Inc.)
• Quest Diagnostics Incorporated
• Quidel Corporation
• Thermo Fisher Scientific Inc.

Helicobacter Pylori Diagnostics Market Report Segmentation: 

By Test Type:

• Non-Invasive Test
• Invasive Test

Non-invasive test represents the largest segment as they do not require specialized equipment or skilled personnel to administer, making them more accessible in various healthcare settings.

By Method:

• Laboratory Based Test
• Point of Care Test

Laboratory based test accounts for the majority of the market share due to its reliability, accuracy, and ability to detect the bacterium efficiently.

By End User:

• Diagnostics Laboratories
• Hospitals
• Others

Diagnostics laboratories hold the biggest market share owing to the growing prevalence of H. pylori infection across the globe.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America enjoys the leading position in the helicobacter pylori diagnostics market on account of advanced healthcare infrastructure coupled with a high prevalence of gastrointestinal disorders.

Global Helicobacter Pylori Diagnostics Market Trends:

Advancements in imaging technologies, such as confocal laser endomicroscopy and narrow-band imaging, aid in the visualization of H. pylori-related lesions and improve the accuracy of endoscopic diagnosis. These technologies complement diagnostic tests by providing additional information for disease staging and treatment planning is driving the demand for H. pylori diagnostics in the endoscopy segment.

Moreover, the increasing awareness among the masses about the health risks associated with H. pylori infection and the availability of screening programs in several countries contribute to higher testing rates, which is supporting the growth of the market.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800